主页 / 药理学 / GPCRs / 7-TM Receptors / Glutamate (Metabotropic) Receptors / Non-selective Metabotropic Glutamate / (±)-ABHD-II

(±)-ABHD-II

Cat. No. 0977 提交评论 说明书 / 分析证书（CoA） / 化学品安全技术说明书（SDS）

Discontinued Product

0977 has been discontinued.

View all Non-selective Metabotropic Glutamate products.
说明： Analogue of ACPD
化学名： (±)-2-exo-Aminobicyclo[2.2.1]heptane-2-endo-7-anti-dicarboxylic acid
说明书
引用文献
评论
文献 (2)
生物活性 技术数据 说明书 参考文献

生物活性 for (±)-ABHD-II

Conformationally constrained structural analogue of ACPD.

技术数据 for (±)-ABHD-II

分子量 199.21
储存 Store at RT

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for (±)-ABHD-II

分析证书目前不在网上提供。
请联系客户服务
化学品安全技术说明书

参考文献 for (±)-ABHD-II

参考文献是支持产品生物活性的出版物。

Tellier et al (1995) Synthesis of conformationally-constrained stereospecific analogs of glutamic acid as antagonists of metabotropic receptors. Bio.Org.Med.Chem.Lett. 5 2627

按标靶查看相关产品

关键词: (±)-ABHD-II, (±)-ABHD-II supplier, Non-selective, mGlu, 0977, Tocris Bioscience

篇 (±)-ABHD-II 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 (±)-ABHD-II 的引用文献。

(±)-ABHD-II 的评论

目前没有该产品的评论。 Be the first to review (±)-ABHD-II and earn rewards!

Have you used (±)-ABHD-II ?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意，Tocris 仅会向正规科研企业/机构地址发送文献。

Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.